Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Petros Pharmaceuticals Inc
PTPI
Healthcare
Petros Pharmaceuticals, Inc. is a pharmaceutical company focused on expanding consumer access to medication through over-the-counter (OTC) drug development programs. The Company is pursuing access to its flagship prescription erectile dysfunction (ED) therapy, Stendra, via potential OTC designation. Stendra is a Phosphodiesterase - 5 (PDE - 5) inhibitor prescription medication for the treatment...
of ED and is the only patent protected PDE-5 inhibitor on the market. Stendra offers the ED therapeutic landscape a valuable addition as an oral ED therapy that may be taken once daily as early as approximately 15 minutes prior to sexual engagement, with or without food, when using the 100mg or 200mg dosing, subject to certain contraindications and limitations common among PDE-5 inhibitors. It also markets its own line of medical devices intended for ED treatment through its subsidiaries, Timm Medical and PTV, including the VED systems marketed as Osbon ErecAid and PosTVac.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:PTPI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(9)
•••
MikeTester
X
Post by
MikeTester
on Aug 01, 2024 8:08pm
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI): Navigating the E
https://beyondspx.com/2024/08/01/petros-pharmaceuticals-inc-nasdaqptpi-navigating-the-evolving-ed-landscape-with-innovative-strategies/
(276)
•••
whytestocks
X
Post by
whytestocks
on Apr 02, 2024 7:15pm
Petros Pharmaceuticals Reports Positive Results in an Initia
JUST IN: $PTPI Petros Pharmaceuticals Reports Positive Results in an Initial Cohort Two-Arm Self-Selection (Phase 2-Equivalent) Study for STENDRA(R) (avanafil) as it Pursues OTC StatusNitrate patients
...more
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 19, 2024 9:11am
PTPI ....Nr and vol /price pop
on watch at $1.60
(276)
•••
whytestocks
X
Post by
whytestocks
on Jan 24, 2024 7:45pm
Petros Pharmaceuticals Announces Two Upcoming FDA Meetings t
NEWS: $PTPI Petros Pharmaceuticals Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA(R) (avanafil) Rx-to-OTC SwitchFDA requests meeting to review the Company's
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 13, 2023 4:30pm
New Press Release - Petros Pharmaceuticals Announces Capital Raise of $15 Million
Provides Update on Progress Toward Over the Counter (non-prescription) Development of STENDRANEW YORK, NY / ACCESSWIRE / July 13, 2023 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI) ("Petros" or "the Company"), a pioneer in expanding consumer access to medication through the over the counter (OTC...
read article.
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 12, 2023 3:14pm
PTPI ....needs a break of $3.50 with volume
No position
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 12, 2023 3:10pm
PTPI ..... This is "make or break" time
Tapping the DTL at $3.28...it's gotta run right now or else
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Jul 12, 2023 3:02pm
RE:PTPI.... next support at $2.89....then $2.70
$2.885 next support ...... Last one out....don't let the door hit ya in the a$$ when ur leavin
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 12, 2023 1:22pm
PTPI...... Remember...don't let The Green Grass Fool Ya !
WILSON PICKETT - DON'T LET THE GREEN GRASS FOOL YOU (RARE CLIP) - Bing video
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 12, 2023 12:57pm
PTPI ..... That move was on "No News"
My original PTPI post was remove by SH because I have a potty mouth....Aw heck.....SH can't handle the truth. My statement basically said..... Fornicate & Die ! That was when the sh price
...more
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 12, 2023 12:48pm
PTPI.... next support at $2.89....then $2.70
Don't blink
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 12, 2023 12:15pm
PTPI..... Big drop from H.O.D
Seen it coming. All the "Frontloaders" baled at the high All the Chasers are Fried
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 12, 2023 11:56am
PTPI...... Let's see how many Chasers get Fried
Over $4 now
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Apr 14, 2023 3:58pm
RE:PTPI....runner on the loose
Not a bad day ..... The H.O.D was $8.50...now at $4.50 When the P.O announcement .????
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 14, 2023 11:28am
PTPI ....this is going to 10 bucks !!!
I betcha
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth
Learn How this Company is Disrupting Point-of-Care Testing
Unique Battery Metals opportunity in Quebec
Discover Options Trading Strategies to Minimize your Tax Burden
Rig Count Soars as Utilization Surpasses Industry Averages
Are PGM mining stocks an attractive area for your next portfolio allocation?
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities